Astellas Pharma (United States)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
54%
Total
Publications
1.7K
Total Open
Publications
918
Total
Citations
52K
Open Access
Percentage
54%
Total
Publications
1.7K
Total Open
Publications
918
Total
Citations
52K
Breakdown
Publisher Open
22%
Both
28%
Other Platform Open
4%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
226
Hybrid 54%
457
No Guarantees 19%
161
Other Platform Open
Domain 84%
462
Institution 19%
103
Other Internet 15%
81
Public 3%
14
Preprint 0%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 463 |
DOI | Other Internet | 62 |
Europe PMC | Domain | 24 |
Unknown Repository | Other Internet | 21 |
Digital Access to Libraries | Institution | 15 |
DANS - Data Archiving and Networked Services | Institution | 15 |
Figshare | Public | 14 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 9 |
Elsevier - Scopus | Institution | 7 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 6 |